Efficacy and Safety of Once-Weekly Efpeglenatide Monotherapy vs Placebo in Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes Care
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of Once-Weekly Efpeglenatide Monotherapy Versus Placebo in Type 2 Diabetes: The AMPLITUDE-M Randomized Controlled Trial
Diabetes Care 2022 Jul 07;45(7)1592-1600, JP Frias, J Choi, J Rosenstock, L Popescu, E Niemoeller, I Muehlen-Bartmer, S BaekFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.